Nevertheless, recent molecular phenotyping demonstrated EGFR‐independent signaling in HPV‐related HNSCC, suggesting that HPV‐positive patients with HNSCC could be less responsive to EGFR inhibitors (Machiels et al., 2015; Seiwert et al., 2015). This evidence concerns the gene EGFR and head and neck squamous cell carcinoma.